Similar articles for PMID: 30465255

Year	Number of Results
1999	1
2001	1
2002	1
2004	2
2006	2
2008	1
2009	1
2010	4
2011	7
2012	14
2013	16
2014	13
2015	19
2016	9
2017	13
2018	12
2019	19
2020	24
2021	42
2022	24
2023	4
2024	0

1

Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.

Mafeld S, Wong JJ, Kibriya N, Stenberg B, Manas D, Bassett P, Aslam T, Evans J, Littler P. Mafeld S, et al. Cardiovasc Intervent Radiol. 2019 Apr;42(4):577-583. doi: 10.1007/s00270-018-2120-z. Epub 2018 Nov 21. Cardiovasc Intervent Radiol. 2019. PMID: 30465255 Free PMC article.

2

Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.

Freeman E, Cheung W, Kavnoudias H, Majeed A, Kemp W, Roberts SK. Freeman E, et al. Cardiovasc Intervent Radiol. 2021 Feb;44(2):247-253. doi: 10.1007/s00270-020-02666-4. Epub 2020 Oct 13. Cardiovasc Intervent Radiol. 2021. PMID: 33051707

3

Percutaneous ablation of peribiliary tumors with irreversible electroporation.

Silk MT, Wimmer T, Lee KS, Srimathveeravalli G, Brown KT, Kingham PT, Fong Y, Durack JC, Sofocleous CT, Solomon SB. Silk MT, et al. J Vasc Interv Radiol. 2014 Jan;25(1):112-8. doi: 10.1016/j.jvir.2013.10.012. Epub 2013 Nov 18. J Vasc Interv Radiol. 2014. PMID: 24262034

4

Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy.

Belfiore MP, Reginelli A, Maggialetti N, Carbone M, Giovine S, Laporta A, Urraro F, Nardone V, Grassi R, Cappabianca S, Brunese L. Belfiore MP, et al. Med Oncol. 2020 Apr 9;37(5):45. doi: 10.1007/s12032-020-01360-2. Med Oncol. 2020. PMID: 32270353

5

Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.

Coelen RJS, Vogel JA, Vroomen LGPH, Roos E, Busch ORC, van Delden OM, Delft FV, Heger M, van Hooft JE, Kazemier G, Klümpen HJ, van Lienden KP, Rauws EAJ, Scheffer HJ, Verheul HM, Vries J, Wilmink JW, Zonderhuis BM, Besselink MG, van Gulik TM, Meijerink MR. Coelen RJS, et al. BMJ Open. 2017 Sep 1;7(9):e015810. doi: 10.1136/bmjopen-2016-015810. BMJ Open. 2017. PMID: 28864693 Free PMC article. Clinical Trial.

6

Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.

Kalra N, Gupta P, Gorsi U, Bhujade H, Chaluvashetty SB, Duseja A, Singh V, Dhiman RK, Chawla YK, Khandelwal N. Kalra N, et al. Cardiovasc Intervent Radiol. 2019 Apr;42(4):584-590. doi: 10.1007/s00270-019-02164-2. Epub 2019 Jan 29. Cardiovasc Intervent Radiol. 2019. PMID: 30697637

7

Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.

Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR. Cheung W, et al. Technol Cancer Res Treat. 2013 Jun;12(3):233-41. doi: 10.7785/tcrt.2012.500317. Epub 2013 Jan 25. Technol Cancer Res Treat. 2013. PMID: 23369152 Free article.

8

Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.

Sutter O, Calvo J, N'Kontchou G, Nault JC, Ourabia R, Nahon P, Ganne-Carrié N, Bourcier V, Zentar N, Bouhafs F, Sellier N, Diallo A, Seror O. Sutter O, et al. Radiology. 2017 Sep;284(3):877-886. doi: 10.1148/radiol.2017161413. Epub 2017 Apr 28. Radiology. 2017. PMID: 28453431

9

Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.

Niessen C, Beyer LP, Pregler B, Dollinger M, Trabold B, Schlitt HJ, Jung EM, Stroszczynski C, Wiggermann P. Niessen C, et al. J Vasc Interv Radiol. 2016 Apr;27(4):480-6. doi: 10.1016/j.jvir.2015.12.025. Epub 2016 Feb 26. J Vasc Interv Radiol. 2016. PMID: 26922979

10

Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.

Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Frühling P, et al. Eur J Surg Oncol. 2017 Apr;43(4):751-757. doi: 10.1016/j.ejso.2016.12.004. Epub 2017 Jan 11. Eur J Surg Oncol. 2017. PMID: 28109674 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

203 results

Results by year